We have identified multiple genetic variants in SLC28A3 and other genes associated with ACT. Combined with clinical risk factors, genetic risk profiling might be used to identify high-risk patients who can then be provided with safer treatment options.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
University of British Columbia, Vancouver, British Columbia.
J Clin Oncol. 2012 May;30(13):1422-8
© Galenicom 1999-2013